Conduit Pharmaceuticals Correlations

CDTTW Stock

0.01 0 31.72%

The current 90-days correlation between Conduit Pharmaceuticals and Cullinan Oncology LLC is -0.15 (i.e., Good diversification). The correlation of Conduit Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Conduit Pharmaceuticals Correlation With Market

Good diversification

The correlation between Conduit Pharmaceuticals and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Conduit Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Moving together with Conduit Stock

0.64	VALN	Valneva SE ADR	Pair Corr
0.61	VCNX	Vaccinex	Pair Corr
0.8	DRMA	Dermata Therapeutics	Pair Corr
0.72	VIRX	Viracta Therapeutics	Pair Corr
0.76	VRCA	Verrica Pharmaceuticals	Pair Corr
0.62	VRPX	Virpax Pharmaceuticals	Pair Corr
0.69	EDIT	Editas Medicine	Pair Corr

Moving against Conduit Stock

0.78	DMAC	DiaMedica Therapeutics	Pair Corr
0.57	DSGN	Design Therapeutics	Pair Corr
0.54	DRUG	Bright Minds Biosciences	Pair Corr
0.54	VIGL	Vigil Neuroscience	Pair Corr
0.52	VERA	Vera Therapeutics	Pair Corr
0.48	DNLI	Denali Therapeutics Downward Rally	Pair Corr
0.43	VCYT	Veracyte	Pair Corr
0.41	VERV	Verve Therapeutics Sell-off Trend	Pair Corr
0.33	DRTS	Alpha Tau Medical	Pair Corr
0.32	EQ	Equillium	Pair Corr
0.32	DOMH	Dominari Holdings	Pair Corr
0.69	VRDN	Viridian Therapeutics	Pair Corr
0.66	VRNA	Verona Pharma PLC	Pair Corr
0.64	VSTM	Verastem	Pair Corr
0.5	VKTX	Viking Therapeutics	Pair Corr
0.38	KTTAW	Pasithea Therapeutics	Pair Corr

Related Correlations Analysis

	CGEM	AVTE	GPCR	NVCT	LYRA	GOSS	INBX
CGEM		-0.5	0.02	-0.21	0.62	-0.1	-0.15	CGEM
AVTE	-0.5		0.08	0.57	-0.37	-0.06	0.5	AVTE
GPCR	0.02	0.08		-0.22	-0.14	0.64	0.28	GPCR
NVCT	-0.21	0.57	-0.22		0.09	-0.36	0.22	NVCT
LYRA	0.62	-0.37	-0.14	0.09		-0.51	-0.5	LYRA
GOSS	-0.1	-0.06	0.64	-0.36	-0.51		0.35	GOSS
INBX	-0.15	0.5	0.28	0.22	-0.5	0.35		INBX
	CGEM	AVTE	GPCR	NVCT	LYRA	GOSS	INBX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

GOSS	+ 0.64	GPCR
LYRA	+ 0.62	CGEM
NVCT	+ 0.57	AVTE
INBX	+ 0.5	AVTE
INBX	+ 0.35	GOSS
INBX	+ 0.28	GPCR

High negative correlations

GOSS	- 0.51	LYRA
INBX	- 0.5	LYRA
AVTE	- 0.5	CGEM
LYRA	- 0.37	AVTE
GOSS	- 0.36	NVCT
NVCT	- 0.22	GPCR

Risk-Adjusted Indicators

There is a big difference between Conduit Stock performing well and Conduit Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Conduit Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CGEM	2.63	(0.30)	(0.04)	0.01	3.72	(2.45)	6.13	(5.68)	14.90
AVTE	2.57	0.53	0.21	0.61	2.14	(3.36)	5.58	(3.86)	19.11
GPCR	2.68	0.10	0.02	0.29	2.71	(3.17)	8.03	(4.47)	21.24
NVCT	3.51	0.70	0.18	0.53	3.53	(3.79)	10.84	(6.81)	29.62
LYRA	3.16	(0.20)	0.00	(0.01)	0.00	0.00	7.69	(8.00)	23.21
GOSS	2.52	0.04	(0.01)	0.22	2.25	(3.92)	6.06	(4.17)	16.84
INBX	2.13	0.49	0.21	0.75	1.83	(2.81)	6.22	(3.38)	16.75

Conduit Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Conduit Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Conduit Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Conduit Pharmaceuticals by comparing valuation metrics with similar companies.

Cullinan Oncology LLC Aerovate Therapeutics Structure Therapeutics American Nuvectis Pharma Lyra Therapeutics Gossamer Bio Inhibrx American Airlines Group Alcoa Corp Apple Inc Best Buy Co Citigroup SentinelOne CVS Health Corp Chevron Corp

Risk & Return

Correlation

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC